About Sahlgrenska Universitetssjukhuset; Jubileumskliniken
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Genentech, Inc.
1
Clinical Trials at Sahlgrenska Universitetssjukhuset; Jubileumskliniken
During the past decade, Sahlgrenska Universitetssjukhuset; Jubileumskliniken conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
2012-12-14
2014-10-15
Completed
122
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sahlgrenska Universitetssjukhuset; Jubileumskliniken
According to Clinical.Site data, the most researched conditions in "Sahlgrenska Universitetssjukhuset; Jubileumskliniken" are
"Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cytomegalovirus Infections" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Sahlgrenska Universitetssjukhuset; Jubileumskliniken" in a lesser frequency.
Clinical Trials Intervention Types at Sahlgrenska Universitetssjukhuset; Jubileumskliniken
Most popular intervention types in "Sahlgrenska Universitetssjukhuset; Jubileumskliniken" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (3 trials), "Paclitaxel" (3 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Sahlgrenska Universitetssjukhuset; Jubileumskliniken
The vast majority of trials in "Sahlgrenska Universitetssjukhuset; Jubileumskliniken" are
5 trials for "All" genders.
Clinical Trials Status at Sahlgrenska Universitetssjukhuset; Jubileumskliniken
Currently, there are NaN active trials in "Sahlgrenska Universitetssjukhuset; Jubileumskliniken".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Sahlgrenska Universitetssjukhuset; Jubileumskliniken,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sahlgrenska Universitetssjukhuset; Jubileumskliniken, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".